A bill to improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.

Bill 118 s 4827, also known as the Dietary Supplement Labeling Act, aims to enhance transparency and accessibility of information regarding dietary supplements. The bill proposes amending the Federal Food, Drug, and Cosmetic Act to mandate that manufacturers of dietary supplements must register their products with the Food and Drug Administration (FDA).

By requiring manufacturers to list their dietary supplements with the FDA, the bill seeks to provide consumers with more accurate and comprehensive information about the ingredients and potential health benefits or risks associated with these products. This increased transparency is intended to help consumers make more informed decisions about the dietary supplements they choose to use.

Overall, the Dietary Supplement Labeling Act aims to improve the regulation and oversight of dietary supplements in order to protect public health and ensure that consumers have access to reliable information about the products they are purchasing.